Simulated Molecular Evolution for Anticancer Peptide Design
- 2 December 2018
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 58 (6) , 1674-1678
Abstract
A computational technique based on a simulated molecular evolution protocol was employed for anticancer peptide (ACP) design. Starting from known ACPs, innovative bioactive peptides were automatically generated in computer‐assisted design–synthesize–test cycles. This design algorithm offers a viable strategy for the generation of novel peptide sequences, without requiring a priori structure–activity knowledge. Sequence morphing and activity improvement were achieved through iterative amino acid variation and selection. Results show that not only the interaction of ACPs with the target membrane is important for their anticancer activity, but also the degree of peptide dimerization, which was corroborated by temperature profiling and electrospray mass spectrometry.Keywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CRSII2_160699)
This publication has 42 references indexed in Scilit:
- Membranolytic anticancer peptidesMedChemComm, 2016
- Synthetic biology for the directed evolution of protein biocatalysts: navigating sequence space intelligentlyChemical Society Reviews, 2014
- Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEaArchives of Pharmacal Research, 2013
- From antimicrobial to anticancer peptides. A reviewFrontiers in Microbiology, 2013
- Membrane-active host defense peptides – Challenges and perspectives for the development of novel anticancer drugsChemistry and Physics of Lipids, 2011
- Studies on Mechanism of Action of Anticancer Peptides by Modulation of Hydrophobicity Within a Defined Structural FrameworkMolecular Cancer Therapeutics, 2011
- Cationic amphiphilic peptides with cancer-selective toxicityEuropean Journal of Pharmacology, 2009
- Studies on anticancer activities of antimicrobial peptidesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2008
- Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatmentExpert Opinion on Investigational Drugs, 2006
- Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation.Proceedings of the National Academy of Sciences, 1991